Drug intelligence / Profile preview

Yiqi Zhuyu Decoction

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Yiqi Zhuyu Decoction (YZD) is a multi-component traditional Chinese medicine (TCM) herbal formulation used as an integrative therapy in oncology. It is primarily studied in combination with standard chemotherapy regimens, such as FOLFOX-4, for the treatment of metastatic colorectal cancer. The decoction is designed to replenish Qi and remove blood stasis (Yiqi Zhuyu) according to TCM principles, aiming to enhance the efficacy of chemotherapy while potentially mitigating side effects and improving patient survival outcomes. As a complex herbal mixture, it does not target a single biological molecule but rather exerts multi-target effects through its various phytochemical constituents.

Other names: 益气逐瘀汤Yiqi Zhuyu Tang

Beyond the preview

Go deeper on Yiqi Zhuyu Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Zhuyu Decoction.

Explore the full profile